BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 20881839)

  • 1. DDIT3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases.
    Mori T; Iwasaki T; Sonoda H; Kawaguchi K; Tomonaga T; Furukawa H; Sato C; Shiraishi S; Taguchi K; Tamiya S; Yoneda R; Oshiro Y; Matsunobu T; Abe C; Kuboyama Y; Ueki N; Kohashi K; Yamamoto H; Nakashima Y; Oda Y
    Hum Pathol; 2024 Mar; 145():56-62. PubMed ID: 38401716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma.
    Sydow S; Piccinelli P; Mitra S; Tsagkozis P; Hesla A; B R De Mattos C; Köster J; Magnusson L; Nilsson J; Ameur A; Wardenaar R; Foijer F; Spierings D; Mertens F
    Commun Biol; 2024 May; 7(1):606. PubMed ID: 38769442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?
    Becker AK; Puladi B; Xie K; Cassataro A; Götzl R; Hölzle F; Beier JP; Knüchel-Clarke R; Braunschweig T
    World J Surg Oncol; 2024 May; 22(1):131. PubMed ID: 38760830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MDM2 Overexpression in Ameloblastomas with
    Tosios KI; Kalogirou EM; Koutlas IG
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of picoeukaryotes in the natural environment by using taxon-specific oligonucleotide probes in association with tyramide signal amplification-fluorescence in situ hybridization and flow cytometry.
    Biegala IC; Not F; Vaulot D; Simon N
    Appl Environ Microbiol; 2003 Sep; 69(9):5519-29. PubMed ID: 12957941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmable peroxidase-assisted signal amplification enables flexible detection of nucleic acid targets in cellular and histopathological specimens.
    Attar S; Browning VE; Liu Y; Nichols EK; Tsue AF; Shechner DM; Shendure J; Lieberman JA; Akilesh S; Beliveau BJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778496
    [No Abstract]   [Full Text] [Related]  

  • 7. Structured Illumination Microscopy and a Quantitative Image Analysis for the Detection of Positive Margins in a Pre-Clinical Genetically Engineered Mouse Model of Sarcoma.
    Fu HL; Mueller JL; Whitley MJ; Cardona DM; Willett RM; Kirsch DG; Brown JQ; Ramanujam N
    PLoS One; 2016; 11(1):e0147006. PubMed ID: 26799613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing of soft tissue tumors.
    Rottmann D; Abdulfatah E; Pantanowitz L
    Diagn Cytopathol; 2023 Jan; 51(1):12-25. PubMed ID: 35808975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Indirect Competitive Enzyme-Linked Immunosorbent Assay and Lateral-Flow Immunochromatographic Strip for the Detection of Digoxin in Human Blood.
    Ling F; Liu L; Kuang H; Cui G; Xu C
    ACS Omega; 2020 Jan; 5(3):1371-1376. PubMed ID: 32010807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.
    Mardekian SK; Solomides CC; Gong JZ; Peiper SC; Wang ZX; Bajaj R
    J Clin Lab Anal; 2015 Nov; 29(6):462-8. PubMed ID: 25132285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review.
    Assi T; Kattan J; Rassy E; Nassereddine H; Farhat F; Honore C; Le Cesne A; Adam J; Mir O
    Crit Rev Oncol Hematol; 2020 Sep; 153():103029. PubMed ID: 32593094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
    Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
    Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
    Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
    Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults.
    Zhang G; Lanigan CP; Goldblum JR; Tubbs RR; Downs-Kelly E
    Arch Pathol Lab Med; 2016 Oct; 140(10):1111-5. PubMed ID: 27684983
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.